EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Advancements in nasopharyngeal carcinoma radiotherapy: Dosimetric evaluation of arc therapy with hippocampal sparing

Fadila Kouhen, Malak Chahid, Hanae El Gouache, Nadia Errafiy, Abdelhak Maghous

Cancer Treatment and Research Communications · 2025

DOI: 10.1016/j.ctarc.2025.100983 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Treatment and Research Communications, 2025. Verfasst von Fadila Kouhen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Mohammed 6 Faculty of Medicine, Rabat, Mohammed VI University of Sciences and Health; Radiotherapy Department, International University Hospital Shei…. Hauptthemen laut MEDLINE: Hippocampus, Radiotherapy, Intensity-Modulated, Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Nasopharyngeal carcinoma (NPC) is located near critical structures like the hippocampus, essential for memory and cognitive function. While Volumetric Modulated Arc Therapy (VMAT) has improved dose conformity in NPC treatment, the integration of hippocampal-sparing (HS) approaches remains underexplored. This study evaluates the dosimetric feasibility and effectiveness of hippocampal-sparing VMAT (HS-VMAT) in NPC, focusing on reducing radiation exposure to the hippocampus while maintaining target volume coverage. METHODS: We conducted a retrospective cohort study of 20 NPC patients treated at Cheikh Khalifa International University Hospital between 2020 and 2023. Each patient underwent two radiotherapy plans: one with hippocampal sparing and one without. Dosimetric parameters for planning target volumes (PTVs) and organs at risk (OARs) were analyzed. Independent samples t-tests were used for statistical analysis with a significance level of p < 0.05. RESULTS: For the high-risk PTV (PTV HR), there were no significant differences in maximum dose (D2 %) between HS and non-HS groups (71.71 ± 0.23 Gy vs. 71.65 ± 0.11 Gy; p = 0.298). The minimum doses (D95 %, D98 %) and mean dose (Dmean) were slightly lower in the HS group, though not statistically significant. For intermediate- and low-risk PTVs, dose metrics remained similar across groups. Hippocampal sparing significantly reduced doses to the hippocampus. The minimum dose (Dmin) decreased from 5.87 ± 2.06 Gy to 3.93 ± 0.45 Gy (p = 0.001), and the maximum dose (Dmax) decreased from 10.73 ± 3.62 Gy to 7.40 ± 1.25 Gy (p = 0.001). Radiation doses to critical structures were also reduced. The brainstem Dmax decreased from 35.68 ± 5.31 Gy to 30.12 ± 4.71 Gy (p = 0.001), and the left parotid gland Dmoy decreased from 21.38 ± 5.38 Gy to 18.32 ± 2.53 Gy (p = 0.029). CONCLUSION: HS-VMAT for NPC effectively reduces hippocampal and critical structure radiation doses without compromising target volume coverage. This technique offers a feasible approach to minimize neurocognitive risks while maintaining treatment efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HippocampusRadiotherapy, Intensity-ModulatedNasopharyngeal CarcinomaNasopharyngeal NeoplasmsOrgan Sparing TreatmentsHumansRetrospective StudiesMaleFemaleOrgans at RiskMiddle AgedRadiotherapy DosageAdultRadiotherapy Planning, Computer-Assisted

Stichwörter der Autor:innen

DosimetryHippocampal-sparing (HS)Nasopharyngeal carcinoma (NPC)Neurocognitive risk reductionVolumetric modulated arc therapy (VMAT)

Autor:innen und Institutionen

  • Mohammed 6 Faculty of Medicine, Rabat, Mohammed VI University of Sciences and Health; Radiotherapy Department, International University Hospital Sheikh Khalifa, Morocco; Laboratory of Neuro-Oncology, Onco-Genetics and P…
  • Mohammed 6 Faculty of Medicine, Rabat, Mohammed VI University of Sciences and Health; Radiotherapy Department, International University Hospital Sheikh Khalifa, Morocco.
  • Mohammed 6 Faculty of Medicine, Rabat, Mohammed VI University of Sciences and Health.
  • Faculty of medicine and Pharmacy Casablanca (FMPC), Hassan II University, Morocco; Mohammed V Military Teaching Hospital, Rabat, Morocco.

Zitieren

APA

Kouhen, F., Chahid, M., Gouache, H. E., Errafiy, N., & Maghous, A. (2025). Advancements in nasopharyngeal carcinoma radiotherapy: Dosimetric evaluation of arc therapy with hippocampal sparing. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2025.100983

Vancouver

Kouhen F, Chahid M, Gouache HE, Errafiy N, Maghous A. Advancements in nasopharyngeal carcinoma radiotherapy: Dosimetric evaluation of arc therapy with hippocampal sparing. Cancer Treatment and Research Communications. 2025. doi:10.1016/j.ctarc.2025.100983

BibTeX
@article{Kouhen2025,
  author = {Kouhen, Fadila and Chahid, Malak and Gouache, Hanae El and Errafiy, Nadia and Maghous, Abdelhak},
  title = {Advancements in nasopharyngeal carcinoma radiotherapy: Dosimetric evaluation of arc therapy with hippocampal sparing},
  journal = {Cancer Treatment and Research Communications},
  year = {2025},
  doi = {10.1016/j.ctarc.2025.100983}
}
Kostenlos starten →